Trial · NCT03407625
Registered outcomes24
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 24
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants With Vaginal Delivery | at delivery | vaginal delivery at first induction |
| Secondary | Time to Delivery | from start of induction agent to time of delivery | Time (in hours) from start of induction agent to delivery at first induction |
| Secondary | Indication for Cesarean Delivery | at delivery | Among women delivered by cesarean, the indication for cesarean |
| Secondary | Dose of Oxytocin Given (mcg or mg) | at delivery | Total dose of oxytocin given for induction as calculated by volume infused, concentration of solution and rate of infusion |
| Secondary | Time With Foley Bulb in Place | From time of documented insertion until the time of documented expulsion or removal, whichever came first, assessed up to 24 hours. | time (in hours) from insertion to removal or expulsion of foley bulb |
| Secondary | Presence of Chorioamnionitis | at delivery | Intrapartum fever (temp equal or greater than 38C) with no other identified cause |
| Secondary | Use of Intravenous Analgesia During Labor | at delivery | Intravenous analgesia used between the start of induction and delivery |
| Secondary | Number of Participants Used Neuraxial Analgesia During Labor | from start of induction to delivery | Regional or neuraxial analgesia (labor epidural or spinal) used between the start of induction and delivery |
| Secondary | Number of Participants Used General Anesthesia for Delivery | at delivery | General anesthesia administered for delivery |
| Secondary | Number of Participants With Meconium-stained Amniotic Fluid | At the time of rupture of membranes and at delivery | Identification of any meconium (green tinge) in the amniotic fluid before or during delivery by a healthcare provider's assessment of gross fluid color. |
| Secondary | Terbutaline Use | at delivery | Administration of terbutaline, a tocolytic agent, for tetanic contractions with or without fetal heart rate decelerations |
| Secondary | Number of Participants With Tachysystole | at delivery | 6 or more contractions in 10 minutes or tetanic contraction of 120 seconds or longer |
| Secondary | Number of Participants With Uterine Hyperstimulation Syndrome | at delivery | Tachysystole accompanied by fetal heart rate decelerations |
| Secondary | Number of Participants With Excess Blood Loss | at delivery | Maternal excess blood loss is defined as \>500ml for vaginal and \>1000ml for cesarean delivery |
| Secondary | Number of Participants With Blood Transfusion | at delivery | administration of blood products related to delivery blood loss |
| Secondary | Number of Participants With Uterine Rupture | at delivery | spontaneous separation of myometrium in a previously intact, unscarred uterus |
| Secondary | Number of Participants With Unplanned Hysterectomy | at discharge from the hospital following delivery | unplanned removal of the uterus following delivery of the fetus |
| Secondary | Number of Participants With Postpartum Fever | Following delivery and prior to discharge | Fever recorded in the time after delivery but prior to discharge from the hospital, with clinical assessment of endometritis |
| Secondary | Number of Participants With Umbilical Cord Blood pH <7.0 | at delivery | Arterial or venous cord blood pH defined as \<7.0 |
| Secondary | Number of Participants With an 5-minute Apgar Score Less Than 4 | 5 minutes after time of birth | Appearance, Pulse, Grimace, Activity, Respirations - scored from 0 to 2 for each component, added to make a total score and used as an assessment of initial response to newborn resuscitation, lower scores associated with poor outcomes. Here defined as Apgar less than 4 at 5 minutes. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03407625/registered